Human Emulation System News Today

BOSTON--(BUSINESS WIRE)--Emulate, Inc., the leading provider of next-generation in vitro models, today announced the publication “Integrating Liver-Chip Data into Pharmaceutical Decision-Making Processes” in Expert Opinion on Drug Discovery. The article introduces a decision-making framework that includes two guidel...

BOSTON--(BUSINESS WIRE)--Sep 15, 2023--

Https://finance.yahoo.com/news/emulate-unveils-chip-a1-expanding-062600640.html Chip-A1 allows researchers to effectively model complex 3D tissues, such as...

Emulate, Inc recently launched the Zoë-CM2 Culture Module, a second-generation Zoë instrument core to its ‘Organ-on-a-Chip’ based Human Emulation System.

Colon Intestine-Chip Introduced for Research on Inflammatory Intestinal Diseases March 17, 2021 Share Emulate launched the Colon Intestine-Chip for researchers investigating inflammatory intestinal diseases. The complete, lab-ready Human Emulation System and the Colon Intestine-Chip will allow researchers to recapitulate specific human colon cell functionality, gain a greater understanding of mechanisms of inflammation, and investigate potential drug targets, says Lorna Ewart, executive vice pr...

Share this article BOSTON, Jan. 8, 2021 /PRNewswire/ -- Emulate, Inc., a leading provider of advanced in vitro models, today announced an application roadmap for their market leading organ-on-a-chip technology that expands beyond small molecule applications and addresses the growing focus on targeted and advanced biologics within drug development. These new human organ models enable the technology to be used within stages of the drug discovery and development process that are iterative, inclu...

Published: Dec 21, 2020 BOSTON, Dec. 21, 2020 /PRNewswire/ -- Emulate, Inc., a leading provider of advanced in vitro models, today unveiled the Emulate Brain-Chip, which is designed for neuroscience researchers investigating neuroinflammatory disease and for drug developers seeking to improve drug discovery for neurodegenerative diseases such as Alzheimers and Parkinsons. The comprehensive model incorporates cells from the human brain, including the blood-brain barrier, in a dynamic microe...

MedCity News Read news from healthcare startups including Outcomes4Me, Emulate, and more. Shares0 Outcomes4Me Inc.and Foundation Medicine Inc. reveals breast cancer patients are not offered genomic testing. Genomic testing allows doctors to learn more about a tumor’s individual characteristics and ultimately provide the patient with more personalized treatment options.” said Osama Rahma, M.D., Co-Founder and Chief Medical Advisor of Outcomes4Me. “Test results can also expand patient ac...